NCT05924178 Effects of Preoperative Rehabilitation on Tendon Healing, Bone Mineral Density, and Cartilage After ACLR and Patellar Dislocation
| NCT ID | NCT05924178 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Peking University Third Hospital |
| Condition | Anterior Cruciate Ligament Rupture |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2023-07-10 |
| Primary Completion | 2026-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2023-07-10 with a primary completion date of 2026-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To explore the effect of preoperative exercise rehabilitation on bone mineral density, tendon bone healing, change of cartilage, and gait feature in patients with anterior cruciate ligament rupture.
Eligibility Criteria
Inclusion Criteria: 1. Age 18\~40 years old, diagnosed ACL rupture or Patellar Dislocation by MRI; 2. The first unilateral ligamenta reconstruction at our hospital; Exclusion Criteria: 1. Be older than 40 years, or less than 18 years old 2. Severe injury to other knee ligaments 3. History of knee trauma
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05924178 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 45 Years, studying Anterior Cruciate Ligament Rupture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05924178 currently recruiting?
Yes, NCT05924178 is actively recruiting participants. Contact the research team at xixishuang123@126.com for enrollment information.
Where is the NCT05924178 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT05924178 clinical trial?
NCT05924178 is sponsored by Peking University Third Hospital. The trial plans to enroll 60 participants.